Phase 2 News

Latest Articles

• Experimental Northwestern University Drug Doubles One-Year Survival Rates in High-Stakes Pancreatic Cancer Clinical Trial

  Published: Apr 14, 2026

  Section: Health Technology

  A phase 2 clinical trial for the drug elraglusib has demonstrated a 38% reduction in the risk of death for patients with metastatic pancreatic cancer when combined with chemotherap...

• Phase 2 Trial of Investigational Hypertension Injection Tonlamarsen Reveals Persistent Protein Suppression but Conflicting Blood Pressure Data

  Published: Mar 30, 2026

  Section: Science & Tech

  Results from the Kardinal trial presented at ACC.26 show that the monthly injectable drug tonlamarsen successfully reduces angiotensinogen levels by over 67%. However, the study fo...